The quality control department did not appropriately approve, assess, and/or document the reprocessing and/or reworking of a lot and/or batch.
Inspection Record
A & C American Chemicals Ltd. — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The quality control department's documentation, labelling, and/or quarantining of raw materials, packaging materials, in-process drugs, and/or bulk drugs was inadequate.
Lots and/or batches of packaging materials were not examined and/or tested against the written specifications before they were used.
The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate.
The written procedures for recalls were inadequate.
The qualification and/or verification of utilities and/or support systems was inadequate.
The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.
The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.
The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.
The quarantine, sampling, testing, release of raw material, and/or the packaging materials prior to use were inadequate.
About this record
Extracted automatically from the document of the Health Canada inspection on 2023-03-07. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
